Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: TELIX PHARMACEUTICALS US INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-11-01 to 2024-10-31
Current total value of award: $334300
Description: MOD DECREASE - ILLUCCIX FOR VASD NUCLEAR MED